NSJ Bioreagents

A VCAM-1 antibody is used to study the expression of VCAM-1, or vascular cell adhesion molecule-1, a cell surface protein that is involved in the adhesion of white blood cells to the endothelium, the inner lining of blood vessels. VCAM-1 is a cell adhesion molecule that is expressed on the surface of endothelial cells in response to inflammatory signals. It plays a key role in the recruitment of white blood cells to sites of inflammation, where they can help fight off infections and repair damaged tissues. VCAM-1 interacts with integrin receptors on the surface of leukocytes, facilitating their adhesion to the endothelium and subsequent migration into tissues.

Potential Applications of VCAM-1 Protein:

1. Inflammation and Immune Responses: VCAM-1 is a critical player in the inflammatory response, allowing immune cells to target and eliminate pathogens. By targeting VCAM-1, researchers may be able to modulate immune responses and potentially develop new treatments for inflammatory diseases.

2. Cardiovascular Diseases: VCAM-1 has been implicated in the development of atherosclerosis, a condition characterized by the buildup of plaques in the arteries. Targeting VCAM-1 could potentially help prevent the progression of atherosclerosis and reduce the risk of heart attacks and strokes.

3. Cancer: VCAM-1 expression has been observed in various types of cancer, where it may contribute to tumor growth and metastasis. By targeting VCAM-1, researchers may be able to develop new therapies to inhibit cancer cell adhesion and migration.

4. Drug Delivery: VCAM-1 has been proposed as a potential target for drug delivery systems, as it is selectively expressed on activated endothelial cells in inflamed tissues. By conjugating drugs to VCAM-1-targeting molecules, researchers may be able to enhance their delivery to sites of inflammation and improve therapeutic efficacy.

VCAM-1 antibody is an important tool in the in the research and characterization of VCAM-1 protein and has a role in various assay techniques such as flow cytometry, western blot, immunohistochemistry, immunocytochemistry, and immunofluorescence.

First and foremost, let's understand what VCAM-1 antibody is. VCAM-1 (Vascular Cell Adhesion Molecule-1) is a cell surface protein that plays a crucial role in the adhesion of leukocytes to the endothelium during inflammation. By targeting VCAM-1 with specific antibodies, researchers can study its expression levels and localization in different cell types and tissues.

Flow cytometry is a powerful technique that allows for the quantitative analysis of cell surface markers, including VCAM-1. By using VCAM-1 antibody in flow cytometry assays, researchers can easily identify and characterize cells expressing VCAM-1. This can provide valuable insights into the immune response and the pathogenesis of inflammatory diseases.

In addition to flow cytometry, Vascular Cell Adhesion Molecule-1 antibody can also be used in western blot analysis to detect the expression of VCAM-1 in cell lysates. This technique helps researchers understand the protein levels of VCAM-1 under different conditions and treatments, shedding light on its regulatory mechanisms.

Immunohistochemistry, immunocytochemistry, and immunofluorescence are other valuable techniques that leverage the specificity of VCAM-1 antibody to visualize the cellular localization of VCAM-1. By staining tissues or cells with VCAM-1 antibody and using fluorescent markers, researchers can observe the distribution of VCAM-1 in various cellular compartments with high precision.

VCAM-1 antibody is a versatile tool that can be employed in a wide range of assay techniques to explore the expression, localization, and function of VCAM-1 in biological systems. Whether you are studying inflammation, immune response, or vascular biology, VCAM-1 antibody is a valuable asset in your research arsenal.

VCAM-1 protein is a fascinating molecule with diverse roles in inflammation, immunity, and disease. By understanding its functions and interactions, researchers may be able to unlock new therapeutic strategies for a variety of conditions, from cardiovascular diseases to cancer. As the field of biomedical research continues to advance, the potential applications of VCAM-1 protein are sure to expand, offering exciting opportunities for innovative treatments and interventions.

This VCAM-1 antibody page is part of a broader CD antibody panel used to study epithelial differentiation, tissue distribution, and tumor classification across multiple keratin family members.

Browse the complete collection of research antibodies on our Antibodies landing page.

<p><strong data-start="0" data-end="37" data-is-only-node="">VCAM-1 Antibody Human Tonsil IHC.</strong> Immunohistochemistry analysis of FFPE human tonsil tissue using VCAM-1 Antibody clone 1.4C3 demonstrates strong HRP-DAB brown membranous staining within lymphoid cell populations. The staining pattern is consistent with the established role of Vascular Cell Adhesion Molecule 1 (VCAM-1/CD106) in leukocyte adhesion, immune cell trafficking, and inflammatory signaling. Prominent cell-surface staining highlights immune cell interactions within secondary lymphoid tissue and supports studies of endothelial activation, adaptive immunity, and leukocyte recruitment pathways.</p>

VCAM-1 Antibody Human Tonsil IHC. Immunohistochemistry analysis of FFPE human tonsil tissue using VCAM-1 Antibody clone 1.4C3 demonstrates strong HRP-DAB brown membranous staining within lymphoid cell populations. The staining pattern is consistent with the established role of Vascular Cell Adhesion Molecule 1 (VCAM-1/CD106) in leukocyte adhesion, immune cell trafficking, and inflammatory signaling. Prominent cell-surface staining highlights immune cell interactions within secondary lymphoid tissue and supports studies of endothelial activation, adaptive immunity, and leukocyte recruitment pathways.